Table I.

Clinico-pathological features of the study population.

Clinico-pathological features	N (%)
Patients	95
Age at diagnosis
Median (years), range	62 (36-82)
Oncological treatment
NACT	41 (43.2%)
PCS	54 (56.8%)
Family history for cancer in first and second degree relatives
Positive	58 (61.1%)
Negative	37 (38.9%)
Histotype
High grade serous carcinoma (HGSOC)	93 (97.9%)
High grade endometrioid carcinoma (HGEOC)	1 (1.1%)
Malignant mixed Mullerian tumor (MMMT)	1 (1%)
tBRCA status
BRCA1/2 wt	87(91.6%)
BRCA1 pathogenic/BRCA2 wt	3 (3.2%)
BRCA1 wt/BRCA2 pathogenic	2 (2.1%)
NA	3 (3.2%)

NACT = neoadjuvant chemotherapy, PCS = primary cytoreductive surgery, tBRCA = tumor BRCA, wt = wild type.